Jiangxi Fushine Pharmaceutical Co.Ltd(300497) accept the survey of 13 institutions! The net inflow of short-term main funds into the market may have long been noticed

Jiangxi Fushine Pharmaceutical Co.Ltd(300497) was surveyed by 13 institutions on January 18, 2022. Among them, there are 11 fund management companies, 1 securities company and 1 investment company. Based on this research event, we found that the company’s main capital flow showed a net purchase of 44.0474 million yuan in the last five trading days. In the trend dimension, the stock prices were running above the 10th and 20th lines, and the market’s willingness to do more increased.